Relugolix Completed Phase 1 Trials for Healthy Volunteers Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT02252354TAK-385 Phase I Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability Study